Viewing Study NCT05124392


Ignite Creation Date: 2025-12-24 @ 3:50 PM
Ignite Modification Date: 2025-12-24 @ 3:50 PM
Study NCT ID: NCT05124392
Status: RECRUITING
Last Update Posted: 2025-11-24
First Post: 2021-10-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Biomarker Profiling in Individuals at Risk for Prion Disease
Sponsor: Massachusetts General Hospital
Organization:

Study Overview

Official Title: Biomarker Profiling in Individuals at Risk for Prion Disease
Status: RECRUITING
Status Verified Date: 2025-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: We are doing this research to identify biomarkers in individuals who are at-risk for familial prion disease. We hope to use these biomarkers to predict timing of disease onset in pre-symptomatic individuals and to guide the direction of future clinical trials.
Detailed Description: This study aims to measure biomarkers longitudinally in individuals at risk of developing genetic prion disease to identify clinical assays and molecular markers that: can inform our understanding of pre-clinical pathology, predict timing of disease onset in pre-symptomatic individuals, and enable development and evaluation of novel treatment efficacy in pre-symptomatic or early symptomatic individuals.

Participation in the study involves annual visits to the clinic site in Charlestown, MA. Study visits include: a medical exam, blood draws, cognitive tests and questionnaires, spinal fluid collection, and (optional) MRI.

Travel support and stipend is provided for interested individuals.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: